Outcome of Patients Treated With ECLS

Recruiting

• Conditions: Cardiac Arrest; Acute Respiratory Distress Syndrome; Acute Respiratory Failure; Heart Failure; Cardiogenic Shock

• Registration Number: NCT04405817
• Lead Sponsor: Nanjing Medical University

Brief Summary

Extracorporeal life support (ECLS), also called extracorporeal membrane oxygenation (ECMO), is an extracorporeal technique of providing effective circulatory and (or) respiratory failure, with a growing number of critically ill patients benefit from it. The aim of this study is to investigate the outcome of patients treated With ECMO, and to evaluate the short-term and long-term outcomes of patients with ECLS.

Detailed Description

Not available

Study Timeline

• Study Start: 2012-01-01
• Status Verified: 2020-05
• Study First Submitted: 2020-05-26
• Study First Submitted QC: 2020-05-26
• Last Update Submitted: 2020-05-26
• Study First Posted: 2020-05-28
• Last Update Posted: 2020-05-28
• Primary Completion: 2025-12-31
• Study Completion: 2025-12-31

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

• Patients receiving ECMO for circulatory and/or respiratory support

Exclusion Criteria

• Refusal of consent

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Composite of death from any cause, resuscitated circulatory arrest, and implantation of another mechanical circulatory support device	30 days after ECMO implantation

Secondary Outcome Measures

Name	Time	Method
All-cause mortality	12 months after ECMO implantation

Trial Locations

Locations (1)

The first affiliated hospital of nanjing medical university; 🇨🇳 Nanjing, Jiangsu, China